HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology.

Abstract
The initial management of immune thrombocytopenic purpura is a topic of debate among pediatric hematologists. The decision whether to start a patient on pharmacotherapy or to employ an approach of watchful waiting and patient education is problematic for this group of physicians. A wide variety of research studies and review articles have been published on either side of this debate. Here, the proceedings from a panel discussion, held at the 2002 American Society of Pediatric Hematology/Oncology meeting, are presented. The panel, composed of experts on both sides of the debate, presented the rationale, benefits, and risks of both pharmacotherapy and the watchful waiting strategy.
AuthorsPaula Bolton-Maggs, Michael D Tarantino, George R Buchanan, James B Bussel, James N George,
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 26 Issue 2 Pg. 146-51 (Feb 2004) ISSN: 1077-4114 [Print] United States
PMID14767210 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Isoantibodies
  • RHO(D) antibody
  • Rho(D) Immune Globulin
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Infant
  • Isoantibodies (administration & dosage, immunology)
  • Male
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy)
  • Rho(D) Immune Globulin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: